| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3187475 | Annales de Dermatologie et de Vénéréologie | 2013 | 6 Pages |
Abstract
Routine screening for cryofibrinogen in plasma should be performed to explore cutaneous symptoms of unexplained thrombotic vasculopathy, even in the presence of a non-specific skin biopsy. Specific treatment of cryofibrinogenaemia associated monoclonal gammopathy appears to be highly effective against manifestations of cryofibrinogenaemia.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
J. Delyon, M. Bezier, F. Cordoliani, M. Malphettes, R. Szalat, M. Bagot, M. Rybojad,